Nov 20, 2019

Letter of Hope from the Oliver Lab

We know how cancer impacts your lives. It has touched our lives too. We want you to know we are working hard every day to uncover clues and new strategies for treating lung cancer. Lung cancer is the number one cause of cancer-related death in the United States and in Utah. Unfortunately, because of the stigma associated with smoking and the relatively few survivors of lung cancer, funding for lung cancer research is relatively low. Yet we know that people of all ages can develop lung cancer, including non-smokers, and our discoveries in lung cancer can affect the treatment of many types of cancer.

Oct 31, 2019

Complex Cellular Machine Visualized to Yield New Insights in Cancer

Cellular machines that control chromosome structure, such as the RSC complex, are mutated in about one-fifth of all human cancers. Now, for the first time, scientists have developed a high-resolution visual map of this multi-protein machine, elucidating how the RSC complex works and what role it has in healthy and cancer cells.

Sep 30, 2019

International Lifetime Achievement Award in Leukemia Research Awarded to Michael Deininger, MD, PhD

The International Chronic Myeloid Leukemia Foundation (iCMLf) has awarded the prestigious Rowley Prize to Michael Deininger, MD, PhD. Deininger’s selection as the 2019 awardee was announced in February. Formal presentation of the prize occurred at an international scientific conference in Bordeaux, France, earlier this month.

Sep 13, 2019

HCI Researcher Deanna Kepka Receives YWCA Outstanding Achievement Award

YWCA Utah presented Deanna Kepka, PhD, MPH, with an Outstanding Achievement Award in Health and Medicine. Kepka is a Huntsman Cancer Institute investigator, assistant professor at the University of Utah College of Nursing, and adjunct assistant professor at the U of U Department of Population Health Sciences. Kepka studies effective strategies for vaccination uptake against human papillomavirus (HPV)-related cancers

Aug 15, 2019

Discovery of How Cells Override Genetic Changes Could Lead to New Approaches in Pancreatic Cancer Treatment

Pancreatic cancer is one of the deadliest cancers. It is difficult to diagnose, is often not found until it has spread to other parts of the body, and is mostly untreatable. A discovery by scientists at Huntsman Cancer Institute at the University of Utah could lead researchers to a more effective way to treat pancreatic cancer.

Aug 01, 2019

BRIGHT Study Finds Genetic Testing Motivates Behavior Changes in Families at Risk for Melanoma

Skin cancer is the most commonly diagnosed cancer in the United States, and melanoma is the most severe type of skin cancer. Utah has a particularly high melanoma rate. A new study led by researchers at Huntsman Cancer Institute collaborators at Northwestern University and Oregon Health and Science University investigated whether genetic testing would motivate people at risk of developing melanoma to alter their behavior in order to reduce their risk.

Jul 26, 2019

2019 State of Huntsman Cancer Institute Address

Huntsman Cancer Institute is celebrating its 20th year since it opened its first building, and has never been in better shape, according to CEO Mary Beckerle, PhD. Beckerle recently delivered her annual State of HCI address to faculty, physicians, staff, and students.

Jul 18, 2019

Huntsman Cancer Institute Researchers Develop Potential New Treatment for MYC-driven Small Cell Lung Cancer

Lung cancer is the leading cause of cancer death among men and women in Utah and the United States. Often, symptoms do not appear until the disease is advanced. Therefore, research studies toward better practices to prevent, find, and treat lung cancer are paramount. Research from scientists at Huntsman Cancer Institute yielded new insights into understanding potential new treatment options for MYC-driven tumors, a distinct subtype of small cell lung cancer.